CN Stock MarketDetailed Quotes
688443 Chongqing Genrix Biopharmaceutical
- 40.66
- +1.29+3.28%
Market Closed May 17 15:00 CST
14.91BMarket Cap-19510P/E (TTM)
40.70High39.03Low18.33KlotVolume39.03Open39.37Pre Close72.97MTurnover2.05%Turnover RatioLossP/E (Static)366.68MShares45.5152wk High5.61P/B3.63BFloat Cap24.1652wk Low47.24Limit Up89.32MShs Float45.51Historical High31.50Limit Down4.24%Amplitude24.16Historical Low--Dividend TTM39.81Avg Price8.63KlotAsk--Div YieldTTM100Lot Size9.04KlotBid
About Chongqing Genrix Biopharmaceutical Company
The company was founded in 2015 and is located in Chongqing International Biotechnology City. It is an innovative biopharmaceutical company driven by antibody drug discovery technology, focusing on treatment fields such as autoimmune diseases, infectious diseases, and tumors, and is engaged in R&D, production and commercialization of antibody drugs. The company's main business is R&D, production and sales of antibody drugs. The company's main products are Celizumab (GR1501), GR1802, GR1603, GR1801, GR2001, GR1803, etc. Company honors: Chongqing's “Specialized, Special and New” Enterprise, Big Data Application Demonstration Enterprise, Zhongtiancoin High-tech Enterprise, etc.
Company Profile
Short Name-A智翔金泰
Company NameChongqing Genrix Biopharmaceutical Co., Ltd.
Listing DateJun 20, 2023
Issue Price37.88
Shares Offered91.68M share(s)
FoundedOct 20, 2015
Chairmanjikuan dan
Legal Representativejikuan dan
General Managerzhiyuan chang
Secretarychunsheng li
Employees547
ProvinceChong Qing Shi
Phone023-61758666-8621
Office AddressArea A, Building 2, No. 699 Maliu Avenue, Banan District, Chongqing
Zip Code401338
Registered AddressArea A, Building 2, No. 699 Maliu Avenue, Banan District, Chongqing
Fax023-61758011
Emailirm@genrixbio.com
Websitehttp://www.genrixbio.com/
Business License91500113MA5U36LJ53
BusinessThe company is an innovation-driven biopharmaceutical enterprise. The company's main business is R&D, production and sales of antibody drugs. The products the company is developing are monoclonal antibody drugs and bispecific antibody drugs.
Company Executives
- Name
- Position
- Salary
- jikuan dan
- Chairman，directors，Core technical personnel
- 1.25M
- liwen liu
- directors，Chief Financial Officer
- 657.70K
- zhigang liu
- directors，Core technical personnel，Chief Scientific Officer
- 1.65M
- zhiyuan chang
- directors，general manager，Core technical personnel
- 1.49M
- chunsheng li
- directors，Board Secretary
- 717.60K
- rensheng jiang
- directors
- --
- yuntong hu
- Independent directors
- 150.00K
- li chen
- Independent directors
- 150.00K
- dongzhi wei
- Independent directors
- 150.00K
- junshan long
- Securities affairs representative
- --
- jiaqian yang
- Chairman of the Supervisory Board，Employee representative supervisor
- 965.10K
- hong fan
- auditors
- --
- li dai
- Deputy General Manager，Core technical personnel
- 1.19M
- wei wang
- Deputy General Manager，Core technical personnel
- 1.17M
- wei wang
- Deputy General Manager，Core technical personnel
- 1.47M
- junhua qian
- chief technology officer，Core technical personnel
- 1.33M
- min kou
- Employee representative supervisor
- 662.80K
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg